GlassScriptPhysician profile
Candace G Malone
NPI 1023550894
$5,720.02
in general payments reported to CMS, 2019-2025
37 companies · $928 in 2025
The $928 reported for 2025 was more than what 85% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $321 · 2022: $1,288 · 2023: $1,738 · 2024: $1,446 · 2025: $928.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,111.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $925.30 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $762.11 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Pfizer INC. | $520.22 | 2022-2025 | |
| Lilly USA, LLC | $451.55 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Dexcom, INC. | $407.94 | 2021-2025 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $312.20 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $277.42 | 2022-2024 | Arexvy, Trelegy Ellipta, Shingrix |
| Intuity Medical INC | $262.23 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Amgen INC. | $228.86 | 2021-2025 | Evenity, Prolia, Krystexxa |
| Bayer Healthcare Pharmaceuticals INC. | $166.77 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $165.30 | 2021-2025 | |
| Astellas Pharma US INC | $123.88 | 2022-2025 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $117.93 | 2022-2024 | Jardiance |
| Otsuka America Pharmaceutical, INC. | $108.03 | 2023-2025 | Rexulti |
| Eisai INC. | $102.14 | 2021-2025 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Candace Malone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.